SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-024753
Filing Date
2024-06-21
Accepted
2024-06-21 16:30:27
Documents
1
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5193
  Complete submission text file 0001493152-24-024753.txt   6732
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Issuer) CIK: 0001904286 (see all company filings)

IRS No.: 853354547 | State of Incorp.: FL
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address MIRA PHARMACEUTICALS, INC. 1200 BRICKELL AVENUE, SUITE 1950 #1183 MIAMI FL 33131
Business Address
Shekhat Denil Nanji (Reporting) CIK: 0002016605 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41765 | Film No.: 241060897